tradingkey.logo
搜尋

Myomo Inc

MYO
添加自選
0.910USD
+0.026+2.97%
收盤 05/15, 16:00美東報價延遲15分鐘
35.17M總市值
虧損本益比TTM

Myomo Inc

0.910
+0.026+2.97%

關於 Myomo Inc 公司

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Inc簡介

公司代碼MYO
公司名稱Myomo Inc
上市日期Jun 12, 2017
CEOGudonis (Paul R)
員工數量184
證券類型Ordinary Share
年結日Jun 12
公司地址137 Portland Street
城市BOSTON
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編02114
電話16179969058
網址https://myomo.com/
公司代碼MYO
上市日期Jun 12, 2017
CEOGudonis (Paul R)

Myomo Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.11M
-13.32%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
553.86K
--
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
358.41K
-21.82%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
131.75K
--
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
80.99K
-73.62%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.11M
-13.32%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
553.86K
--
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
358.41K
-21.82%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
131.75K
--
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
80.99K
-73.62%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025Q3
FY2025Q2
FY2025Q1
業務USD
名稱
營收
佔比
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%

股東統計

更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Rosalind Advisors, Inc.
9.94%
Horton Capital Management LLC
5.07%
BlackRock Institutional Trust Company, N.A.
3.96%
Vanguard Capital Management, LLC
2.96%
Gudonis (Paul R)
2.88%
其他
75.19%
持股股東
持股股東
佔比
Rosalind Advisors, Inc.
9.94%
Horton Capital Management LLC
5.07%
BlackRock Institutional Trust Company, N.A.
3.96%
Vanguard Capital Management, LLC
2.96%
Gudonis (Paul R)
2.88%
其他
75.19%
股東類型
持股股東
佔比
Hedge Fund
16.43%
Investment Advisor
12.82%
Investment Advisor/Hedge Fund
7.64%
Individual Investor
6.78%
Research Firm
4.41%
Venture Capital
0.42%
Bank and Trust
0.14%
Pension Fund
0.12%
Family Office
0.03%
其他
51.20%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
185
23.44M
63.19%
-5.84M
2025Q4
169
22.12M
57.56%
-3.94M
2025Q3
153
21.95M
58.07%
-1.84M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Rosalind Advisors, Inc.
3.84M
9.97%
+48.98K
+1.29%
Dec 31, 2025
Horton Capital Management LLC
1.96M
5.09%
+1.96M
--
Dec 24, 2025
BlackRock Institutional Trust Company, N.A.
1.53M
3.97%
+34.56K
+2.31%
Dec 31, 2025
Gudonis (Paul R)
1.26M
3.27%
+11.64K
+0.93%
Jan 12, 2026
Geode Capital Management, L.L.C.
736.97K
1.91%
-67.47K
-8.39%
Dec 31, 2025
Jefferies LLC
704.27K
1.83%
+704.27K
--
Dec 31, 2025
Kirk (Thomas F)
553.86K
1.44%
+72.00K
+14.94%
Mar 13, 2026
Goldman Sachs & Company, Inc.
466.70K
1.21%
-566.87K
-54.85%
Dec 31, 2025
AQR Capital Management, LLC
434.38K
1.13%
+140.43K
+47.77%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares UltraPro Russell2000
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI